SANUWAVE Health, Inc.
Research SANUWAVE Health, Inc. (SNWV) on Bullrun: market cap USD 42.67M, P/E 20.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNWV
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 42.67M
- P/E20.6
- Financial periodQ2 2026
- RevenueUSD 9.74M
- Net income-USD 682.00K
- Free cash flow-USD 22.00K
- Gross margin76.2%
Valuation Snapshot
latest market cap is USD 42.67M; P/E is 20.6.
Peer valuation comparison
Latest P/E is 20.62x versus a Healthcare sector median of 21.74x (5.2% below).
Latest P/E is 20.62x versus a United States median of 23.81x (13.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 44.05M | USD 11.81M | USD 1.93M | 77.1% | 0.41 | USD 11.96M | USD 22.97M | USD 1.62M |
| FY2024 | USD 32.63M | -USD 33.08M | USD 1.97M | 75.2% | -7.03 | USD 10.24M | USD 25.80M | -USD 15.80M |
| FY2023 | USD 20.40M | -USD 25.81M | -USD 4.54M | 70.4% | -12.19 | USD 1.80M | USD 30.45M | -USD 43.18M |
| FY2022 | USD 16.74M | -USD 10.29M | -USD 17.17M | 74.1% | -7.5 | USD 1.15M | USD 38.98M | -USD 41.01M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 42.67M | 20.6 | n/a | n/a |
| 2025 | 2025-12-31 | USD 256.29M | n/a | n/a | n/a |
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SANUWAVE Health, Inc.'s market cap?
SANUWAVE Health, Inc.'s market capitalization is USD 42.67M.
What is SANUWAVE Health, Inc.'s P/E ratio?
SANUWAVE Health, Inc.'s price-to-earnings (P/E) ratio is 20.6.
What does SANUWAVE Health, Inc. do?
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds.